OTCMKTS:ARSUF Fagron (ARSUF) Stock Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free ARSUF Stock Alerts $18.59 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$18.59▼$18.5950-Day Range$18.06▼$19.2652-Week Range$16.15▼$19.26VolumeN/AAverage Volume3,287 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield2.90%Price TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Fagron alerts: Email Address Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About Fagron Stock (OTCMKTS:ARSUF)Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.Read More ARSUF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARSUF Stock News HeadlinesOctober 13, 2022 | finance.yahoo.comFagron delivers topline growth of 21.5% to €173 millionSeptember 27, 2022 | finance.yahoo.comFagron commits to set science-based emission reduction targetsMarch 28, 2024 | Insiders Exposed (Ad)This consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.September 8, 2022 | reuters.comFAGRO.BR - Fagron NV | Stock Price & Latest News | ReutersSeptember 4, 2022 | yahoo.comDisclosure of received notification of Kabouter Management LLCAugust 8, 2022 | seekingalpha.comFagron NV (ARSUF) CEO Rafael Padilla on Q2 2022 Results - Earnings Call TranscriptAugust 4, 2022 | finance.yahoo.comFagron delivers strong topline growth of 18.8% and an increase in REBITDA of 13.1% for the first half of 2022June 13, 2022 | finance.yahoo.comFagron increases share capital through exercise subscription rightsMarch 28, 2024 | Insiders Exposed (Ad)This consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.May 9, 2022 | ca.finance.yahoo.comFagron shareholders approve all voting items AGM and EGMApril 14, 2022 | uk.finance.yahoo.comFagron reports 16% increase in revenue to € 156.4 millionApril 8, 2022 | nz.finance.yahoo.comFagron publishes agenda 2022 annual general meeting and extraordinary general meetingMarch 15, 2022 | msn.comFagron expands Wichita facility, creating 150 new jobsMarch 15, 2022 | finance.yahoo.comFagron to present medium-term strategic objectives at its Capital Markets DayMarch 7, 2022 | sg.finance.yahoo.comFull year ‘21 results Fagron in line with expectationsFebruary 2, 2022 | finance.yahoo.comFagron strengthens position in US with acquisition of Letco and divestment of non-core activitiesSee More Headlines Receive ARSUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fagron and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:ARSUF CUSIPN/A CIKN/A Webwww.fagron.com Phone32.8.001.28.80FaxN/AEmployees3,035Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Rafael Padilla (Age 46)CEO & Executive Director Comp: $708.91kMs. Karin de Jong (Age 45)CFO & Executive Director Comp: $1.09MMs. Vera Bakker (Age 52)Chief Operating Officer Comp: $8.17kKaren BergGlobal Investor Relations ManagerMr. Johan VerlindenHead of Legal, Mergers & AcquisitionsKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors ARSUF Stock Analysis - Frequently Asked Questions How have ARSUF shares performed in 2024? Fagron's stock was trading at $18.4794 on January 1st, 2024. Since then, ARSUF stock has increased by 0.6% and is now trading at $18.5893. View the best growth stocks for 2024 here. Is Fagron a good dividend stock? Fagron (OTCMKTS:ARSUF) pays an annual dividend of $0.54 per share and currently has a dividend yield of 1.72%. How do I buy shares of Fagron? Shares of ARSUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ARSUF) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fagron NV Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.